EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan, X Xu, C Xie - OncoTargets and therapy, 2014 - Taylor & Francis
Introduction Brain metastases are one of the leading causes of death from non-small-cell
lung cancer (NSCLC). The use of epidermal growth factor receptor (EGFR) tyrosine kinase …
被引用次数：60 相关文章

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data.

Y Fan, X Xu, C Xie - Oncotargets and Therapy, 2014 - europepmc.org
Methods Several data sources were searched, including PubMed, Web of Science, and
ASCO Annual Meetings databases. The end points were intracranial overall response rate …
[PDF] researchgate.net

[PDF][PDF] egFr-TKi therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan - OncoTargets and Therapy, 2014 - researchgate.net
Results: Sixteen published studies were included in this analysis, with a total of 464 enrolled
patients. The EGFR mutational status was unknown for 362 (unselected group), and 102 …

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan, X Xu, C Xie - OncoTargets and Therapy, 2014 - go.gale.com
Methods: Several data sources were searched, including PubMed, Web of Science, and
ASCO Annual Meetings databases. The end points were intracranial overall response rate …

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data.

Y Fan, X Xu, C Xie - OncoTargets & Therapy, 2014 - search.ebscohost.com
Introduction: Brain metastases are one of the leading causes of death from non-small-cell
lung cancer (NSCLC). The use of epidermal growth factor receptor (EGFR) tyrosine kinase …
[PDF] psu.edu

[PDF][PDF] egFr-TKi therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan - OncoTargets and Therapy, 2014 - Citeseer
Results: Sixteen published studies were included in this analysis, with a total of 464 enrolled
patients. The EGFR mutational status was unknown for 362 (unselected group), and 102 …

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan, X Xu, C Xie - OncoTargets and Therapy, 2014 - dovepress.com
Methods: Several data sources were searched, including PubMed, Web of Science, and
ASCO Annual Meetings databases. The end points were intracranial overall response rate …

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan, X Xu, C Xie - OncoTargets and therapy, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction Brain metastases are one of the leading causes of death from non-small-cell
lung cancer (NSCLC). The use of epidermal growth factor receptor (EGFR) tyrosine kinase …
[PDF] scienceopen.com

[PDF][PDF] egFr-TKi therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan - OncoTargets and Therapy, 2014 - scienceopen.com
Results: Sixteen published studies were included in this analysis, with a total of 464 enrolled
patients. The EGFR mutational status was unknown for 362 (unselected group), and 102 …
[PDF] semanticscholar.org

[PDF][PDF] egFr-TKi therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Y Fan - OncoTargets and Therapy, 2014 - pdfs.semanticscholar.org
Results: Sixteen published studies were included in this analysis, with a total of 464 enrolled
patients. The EGFR mutational status was unknown for 362 (unselected group), and 102 …